Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide

Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide

Bibliographic Details
Main Authors:	Hua-Rui Fu, Ting-Ting Yang, Yan-Min Zhao, Ya-Min Tan, Qi-Qi Gao, He Huang, Ji-Min Shi, Peng Lyu
Format:	Article
Language:	English
Published:	Wolters Kluwer 2021-11-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000001488

Similar Items

Management of Epstein–Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
by: Li Liu, et al.
Published: (2020-04-01)

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder
by: Adam Braun, et al.
Published: (2023-08-01)

Synthesis and Crystal Structure Analysis of Histone Deacetylase Inhibitor Chidamide
by: Bo Han, et al.
Published: (2023-06-01)

Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation
by: S. Feuillet, et al.
Published: (2009-01-01)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
by: Wook Youn Kim, et al.
Published: (2019-03-01)

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
by: Ting-Ting Yang, et al.
Published: (2021-04-01)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
by: Mario Henrique M. Barros, et al.
Published: (2023-09-01)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
by: Shigeyoshi Fujiwara, et al.
Published: (2019-07-01)

Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients
by: Heloisa Helena de Sousa Marques, et al.
Published: (2014-10-01)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
by: Eri Ishikawa, et al.
Published: (2021-07-01)

Epstein-Barr virus-positive T/NK-cell lymphoproliferative diseases in children and adolescents
by: Young-Hyeh Ko
Published: (2018-03-01)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
by: Junhong Ai, et al.
Published: (2018-10-01)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
by: Jennifer L. Crombie, et al.
Published: (2019-03-01)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
by: Masaaki Hotta, et al.
Published: (2018-05-01)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
by: Takeo Mukai, et al.
Published: (2023-09-01)

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
by: Rebecca E. Schultze-Florey, et al.
Published: (2018-06-01)

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
by: Ana Marcela Rojas Fonseca-Hial, et al.
Published: (2016-06-01)

Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers
by: Saime Paydaş, et al.
Published: (2013-09-01)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
by: Xuan Li, et al.
Published: (2012-08-01)

Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes
by: Ayumi Fujimoto, et al.
Published: (2020-02-01)

Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder
by: Elshafa Hassan Ahmed, et al.
Published: (2023-06-01)

P1561: HBSAG-POSITIVE PATIENTS WITH CO-REACTIVATION OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUSES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATED WITH POOR SURVIVAL
by: Jinhua Ren, et al.
Published: (2023-08-01)

Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders
by: Xi Yang, et al.
Published: (2015-10-01)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
by: Yumiko Ban, et al.
Published: (2020-07-01)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
by: Sanjay de Mel, et al.
Published: (2019-01-01)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
by: Mineui Hong, et al.
Published: (2015-11-01)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
by: Ndeye Soukeyna Diop, et al.
Published: (2021-06-01)

Allogeneic hematopoietic stem cell transplantation with the modified myeloablative conditioning regimen for children with chronic active Epstein–Barr virus infection
by: Yanhui Luo, et al.
Published: (2022-12-01)

A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL
by: Chong Wei, et al.
Published: (2021-06-01)

Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
by: Charlotte Syrykh, et al.
Published: (2021-07-01)

Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
by: Seiji Kakiuchi, et al.
Published: (2020-12-01)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
by: Sylvain Latour, et al.
Published: (2018-06-01)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
by: Thomas Mika, et al.
Published: (2019-12-01)

Chidamide acts on the histone deacetylase‐mediated miR‐34a/Bcl‐2 axis to regulate NB4 cell line proliferation and apoptosis
by: Jie Peng, et al.
Published: (2020-12-01)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
by: Mohsen eNavari, et al.
Published: (2014-12-01)

An adult case of systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorder with severe hepatic dysfunction and megalosplenia
by: Xiaoqin Liu, et al.
Published: (2015-06-01)

Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic IL2RG Mutation
by: Kay Tanita, et al.
Published: (2019-02-01)

Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
by: Pascal Roland Enok Bonong, et al.
Published: (2021-03-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
by: Alison Felipe Bordini Biggi, et al.
Published: (2022-03-01)